Abstract
The objective of this study was to synthesize potent and/or novel inhibitors for α-chymotrypsin activity. Eighteen derivatives of N-methylphenyl-N′-(alkyl/aryl) urea (1–18) were synthesized, and their inhibitory effects on α-chymotrypsin enzyme were evaluated. Two compounds exhibited potent inhibitory activities. The most potent, N-(2-methylphenyl)-2-oxo-1-pyrrolidinecarboxamide (15) having a methyl group at ortho position was the most active inhibitor with an IC50 value of 8.10 ± 0.14 μM, which was comparable to standard chymostatin (IC50 = 8.24 ± 0.11 μM). A slightly less potent, N-(2-acetylphenyl)-N′-(3-methylphenyl) urea (10), exhibited an IC50 of 13.6 ± 0.23 μM. Compounds 3, 4, 7, 11, and 13 exhibited moderate activities. The results demonstrated that α-chymotrypsin inhibition is related to the position of the methyl group and the presence of substituent at the nitrogen of the urea bridge. The inhibitory trend suggests that α-chymotrypsin inhibitory activity declines with ortho > meta > para substitution order. In conclusion, our data suggest that the compound 15 may serve as a lead compound for further designing of other potent or novel α-chymotrypsin inhibitors.
Similar content being viewed by others
References
Akira K, Satoshi O, Hitoshi S, Satoshi T, Tatsumi H, Akio M (1988) Benzoylphenylurea derivative and its use as an insecticide. US Patent 4734436
Berquin IM, Sloane BF (1996) Cathepsin B expression in human tumors. Adv Exp Med Biol 389:281–294
Bruce MI, Zwar JA (1966) Cytokinin activity of some substituted ureas and thioureas. Proc R Soc Lond Ser B Biol Sci 165:245–265
Cannell RJP, Kellam SJ, Owsianka AM, Walker JM (1988) Results of a large screen of microalgae for production of protease inhibitors. Planta Med 54:10–14
Castro JL, Ball RG, Broughton HB, Russell MGN, Rathbone D, Watt AP, Baker R, Chapman KL, Fletcher AE, Patel S, Smith AJ, Marshall GR, Ryecroft W, Matassa VG (1996) Controlled modification of acidity in cholecystokinin β-receptor antagonists: N-(1,4-Benzodiazepin-3-yl)-N′-[3-(tetrazol-5-yl-amino) phenyl]ureas. J Med Chem 39:842–849
Derek CM, Andrea JV, Bruce MC, Andrew DA (2003) Ring-deactivated hydroxyalkylpyrrole-based inhibitors of α-chymotrypsin: synthesis and mechanism of action. Org Biomol Chem 1(12):2103–2110
Finar IL (2003) Organic chemistry, 6th edn, vol 1. Pearson Education Asia Ltd, Hong Kong, p 460
Fischer A, Koenig KH, Steinbrunn G, Zschocke A (1972) N-Phenyl-N′-ester urea derivatives. US Patent 3671586
Gilbert L, Olivier M, Mark M, Anne D, Mauricette B (2006) Diphenylurea compounds. US Patent No. 7026357
Groszek GA (2002) Convenient method of synthesis of unsymmetrical urea derivatives. Org Proc Res Dev 6:759–761
Hossein P, Snutch DY, Terrance P (2010) Urea derivatives as calcium channel blockers. US Patent 7659395
Igarashi S, Futagawa M, Tanaka N, Kawamura Y, Morimoto K (1998) Urea derivatives, and industrial antibacterial and antifungal agents, algaecides and antiperiphytic agents containing the same. Japanese Patent International Publication No. WO/1998/039289
Katritzky AR, Pleynet DPM, Yang BA (1997) General synthesis of unsymmetrical tetrasubstituted ureas. J Org Chem 62:4155–4158
Khan KM, Saeed S, Ali M, Gohar M, Zahid J, Khan A, Perveen S, Choudhary MI (2009) Unsymmetrically disubstituted urea derivatives: a potent class of antiglycating agents. Bioorg Med Chem 17:2447–2451
Lam PYS, Jadhav PK, Eyermann CJ, Hodge CN, Ru Y, Bacheler LT, Meek JL, Otto MJ, Rayner MM, Wong YN, Chang CH, Weber PC, Jackson DA, Sharpe TR, Erickson-Viitanen S (1994) Rational design of potent, bio-available non peptide cyclic ureas as HIV protease inhibitors. Science 263:380–384
Patick AK, Potts KE (1998) Protease inhibitors as antiviral agents. Clin Microbiol Rev 11:614–627
Perveen S (2008) A process for the preparation of “Urchym” a urease and α-chymotrypsin enzyme inhibitory drug. US Publication US-2008-221214-A1
Perveen S (2010) “Gaschem” a urease and α-chymotrypsin enzyme inhibitory drug UK Patent No. GB2443892
Perveen S (2011) A process for the preparation of “Urchym” a urease and α-chymotrypsin enzyme inhibitory drug. Pakistan Patent No. 139927
Perveen S, Khan KM, Lodhi MA, Choudhary MI, Atta-ur-Rahman, Voelter W (2008) Urease and α-chymotrypsin inhibitory effects of selected urea derivatives. Lett Drug Des Discov 5:401–405
Sherif AFR (2006) Synthesis and in vitro antitumor evaluation of some indeno [1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems. Bioorg Med Chem 14:6475–6485
Yonova PA, Stoilkova GM (2005) Synthesis and biological activity of urea and thiourea derivatives from 2-aminoheterocyclic compounds. J Plant Grow Reg 23:280–291
Acknowledgments
The authors gratefully acknowledge the Higher Education Commission (HEC) for granting fellowship to Ph. D. student Ms. Sana Mustafa. Authors are also grateful to Dr. Rafat Ali Siddiqui, Cellular Biochemistry Laboratory, Methodist Research Institute, Room E504, Indianapolis, IN 46202, USA for his kind guidance in the preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Perveen, S., Mustafa, S., Latif, M. et al. Unsymmetrical 1,3-disubstituted urea derivatives as α-chymotrypsin inhibitors. Med Chem Res 23, 3585–3592 (2014). https://doi.org/10.1007/s00044-014-0930-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-014-0930-3